Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amylin
Debbie L. Hay
Headache The Journal of Head and Face Pain (2017) Vol. 57, Iss. S2, pp. 89-96
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Jesús Burillo, Patricia Marqués, Beatriz Jiménez, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1236-1236
Open Access | Times Cited: 135
Calcitonin Gene‐Related Peptide Modulators – The History and Renaissance of a New Migraine Drug Class
Richard Hargreaves, Jes Olesen
Headache The Journal of Head and Face Pain (2019) Vol. 59, Iss. 6, pp. 951-970
Closed Access | Times Cited: 116
Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion
Lars Edvinsson, Anne-Sofie Grell, Karin Warfvinge
Journal of Molecular Neuroscience (2020) Vol. 70, Iss. 6, pp. 930-944
Open Access | Times Cited: 71
Mode and site of action of therapies targeting CGRP signaling
Alejandro Labastida‐Ramírez, Edoardo Caronna, Cédric Gollion, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 33
Future targets for migraine treatment beyond CGRP
Linda Al‐Hassany, Deirdre M. Boucherie, Hannah Creeney, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 29
A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene‐related peptide and beyond
Michael L. Garelja, Debbie L. Hay
Headache The Journal of Head and Face Pain (2022) Vol. 62, Iss. 9, pp. 1093-1104
Open Access | Times Cited: 23
Migraine Treatment: Towards New Pharmacological Targets
Marcello Silvestro, Luigi Francesco Iannone, Ilaria Orologio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12268-12268
Open Access | Times Cited: 16
Molecular Anatomy of Synaptic and Extrasynaptic Neurotransmission Between Nociceptive Primary Afferents and Spinal Dorsal Horn Neurons
Miklós Antal
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2356-2356
Open Access
Amylin inhibits gastric cancer progression by targeting CCN1 and affecting the PI3K/AKT signalling pathway
Li Liu, Wenxuan Liu, Wenhong Deng
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy
Ramiro Vázquez, María E. Riveiro, Caroline Berenguer‐Daizé, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 27
The Dual Amylin and Calcitonin Receptor Agonist KBP-088 Induces Weight Loss and Improves Insulin Sensitivity Superior to Chronic Amylin Therapy
Anna Thorsø Larsen, Nina Sonne, Kim Vietz Andreassen, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 370, Iss. 1, pp. 35-43
Open Access | Times Cited: 28
Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies
Andrea Negro, Paolo Martelletti
Expert Review of Neurotherapeutics (2019) Vol. 19, Iss. 8, pp. 769-776
Closed Access | Times Cited: 27
The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy
Anna Thorsø Larsen, Nina Sonne, Kim Vietz Andreassen, et al.
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 374, Iss. 1, pp. 74-83
Open Access | Times Cited: 27
CGRP, Amylin, Immunology, and Headache Medicine
Frederick R. Taylor
Headache The Journal of Head and Face Pain (2018) Vol. 59, Iss. 1, pp. 131-150
Open Access | Times Cited: 27
Calcitonin-gene-related peptide pathway mAbs and migraine prevention
Koen Paemeleire, Antoinette MaassenVanDenBrink
Current Opinion in Neurology (2018) Vol. 31, Iss. 3, pp. 274-280
Closed Access | Times Cited: 25
Identifying New Antimigraine Targets: Lessons from Molecular Biology
Lars Edvinsson, Kristian Agmund Haanes
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 217-225
Open Access | Times Cited: 19
Biological and small molecule strategies in migraine therapy with relation to the calcitonin gene‐related peptide family of peptides
Lars Edvinsson, Jacob C. A. Edvinsson, Kristian Agmund Haanes
British Journal of Pharmacology (2021) Vol. 179, Iss. 3, pp. 371-380
Open Access | Times Cited: 18
Targets for migraine treatment: beyond calcitonin gene-related peptide
David Moreno‐Ajona, María Dolores Villar‐Martínez, Peter J. Goadsby
Current Opinion in Neurology (2021) Vol. 34, Iss. 3, pp. 363-372
Closed Access | Times Cited: 17
NN1213 – A Potent, Long-Acting, and Selective Analog of Human Amylin
Kirsten Dahl, Kirsten Raun, Jakob Lerche Hansen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11688-11700
Open Access | Times Cited: 2
The Calcitonin/Calcitonin Gene-Related Peptide Family in Invertebrate Deuterostomes
Toshio Sekiguchi
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 18
Characterization of transit rates in the large intestine of mice following treatment with a CGRP antibody, CGRP receptor antibody, and small molecule CGRP receptor antagonists
Kirk W. Johnson, Xia Li, Xiaofang Huang, et al.
Headache The Journal of Head and Face Pain (2022) Vol. 62, Iss. 7, pp. 848-857
Open Access | Times Cited: 9
Salmon Calcitonin Attenuates Some Behavioural Responses to Nicotine in Male Mice
Cajsa Aranäs, Jesper Vestlund, Sarah Witley, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 12
A contemporary biological pathway of islet amyloid polypeptide for the management of diabetic dementia
Sushil Kumar Sah, Vijaya Paul Samuel, Sunita Dahiya, et al.
Chemico-Biological Interactions (2019) Vol. 306, pp. 117-122
Closed Access | Times Cited: 11
Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor
Andrew Blumenfeld, Paul L. Durham, Alexander Feoktistov, et al.
Neurology and Therapy (2021) Vol. 10, Iss. 2, pp. 469-497
Open Access | Times Cited: 10
A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system
Shu‐Ting Chen, Jr‐Wei Wu
Progress in brain research (2020), pp. 123-142
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top